Skip to main content

TYVASO DPI IS NOW APPROVED

WHAT MAKES TYVASO THE #1 PRESCRIBED
PROSTACYCLIN
TREATMENT?1*

The 3 E’s OF TYVASO DPI:

EASY-to-use prostacyclin
delivery2,3

EXPLORE DELIVERY

Proven EFFICACY and SAFETY
across multiple clinical trials2-5

VIEW EFFICACY

An option for appropriate
patients identified EARLY2,4,6,7

DISCOVER DOSING

*Based on overall prostacyclin prescribing data as of Dec. 31, 2022.1

TAKE ANOTHER LOOK AT
WHAT TYVASO CAN DO

United Therapeutics Cares™ Co-Pay Assistance Program

AS LITTLE AS
AS LITTLE AS 

$0

PER CO-PAY

United Therapeutics offers a Co-Pay Assistance Program for eligible patients.

Learn More